2017 Clinical Guide to Ophthalmic Drugs 21st ed (2017) by Ron Melton MD PDF

Description

Welcome to the 2017 edition of our annual Clinical Guide to Ophthalmic Drugs. Although the market has not yielded an avalanche of new drugs to share with our readers this year, we will discuss myriad ways to better use most of the medicines already available. Further, we will offer a variety of clinical pearls to help you provide better care to your patients. The areas of eye care most germane to optometry involve two chronic conditions: dry eye disease and glaucoma. These two disease processes make up more than 50% of our patient population. The two newest drugs that currently, or soon will, grace our therapeutic armamentarium are designed for patients with these conditions: Xiidra (lifitegrast 5% ophthalmic solu tion) for treatment of signs and symptoms of dry eye disease, approved by the FDA in July 2016; and soon-to-be released Vyzulta (latanoprostene bunod 0.24% ophthalmic solution) for glaucoma, which would be the first nitric oxide-donating prostaglandin F2 analog available for open-angle glau coma or ocular hypertension. As we become more seasoned clinicians and educators, we feel a duty to our profession to find the next generation of authors to carry on when we step aside in several years. Toward that end, we are pleased to introduce Patrick Vollmer, OD, a 2015 graduate of the Indiana University School of Optometry who completed his residency at William Jennings Bryan Dorn VA Medical Center, and who owns a private practice in Shelby, NC. Dr. Vollmer is contributing to this year’s drug guide, and we are happy to have a third set of hands on this mammoth project. You can find Dr. Vollmer’s complete CV on our website, www.eyeupdate.com. We’d also like to thank our primary peer reviewers Bruce Onofrey, OD, RPh, FAAO, and Tammy Than MS, OD, FAAO, for taking time to review this publication. We are grateful that Bausch + Lomb and Review of Optometry continue to partner with us to produce this unique resource for our profession that we have put out for more than two decades. We hope what is shared with you herein can enhance the excellent care you already provide your patients.

Reviews